Dear Sir, White-coat hypertension (WCHT) is a condition in which patients have high clinical blood pressure (CBP), but it is ambulatory normal. The risk profile of WCHT has not yet been completely clear, and it is not known whether it represents a separate clinical entity, a prehypertensive state, or a low-risk stratum of essential hypertension. 1 Some studies have shown that WCHT represents a low-risk group, 2 whereas others have not. 3 During the last 10 years, several risk markers for atherosclerosis such as fibrinogen and D-dimer have been identified. Fibrinogen is a major determinant of blood viscosity, and it is also involved in haemostasis/thrombosis pathway. D-Dimer is a marker of increased fibrin turnover and ongoing intravascular fibrin formation. 4 Fibrinogen is a major independent risk factor for coronary artery, cerebrovascular, and peripheral vascular disease in the general population. 5 Similarly, elevations of Ddimer are associated with increased risk of future myocardial infarction, stroke, and peripheral vascular disease. 6 Several studies have shown that essential hypertension is associated with increased levels of plasma fibrinogen and D-dimer, indicating a decreased fibrinolytic capacity. 4 Hovewer, there has been no study about levels of plasma fibrinogen and D-dimer in subjects with WCHT in the literature.
The aim of this study was to investigate abnormalities of haemorheology (fibrinogen) and thrombogenesis (D-dimer) in subjects with WCHT.
Age, sex, and body mass index (BMI) matched 30 healthy subjects, 30 patients with WCHT, and 30 patients with essential hypertension were included in the study. Treatments that might interfere with the coagulation system, obesity, diabetes mellitus, and advanced renal failure, were excluded because these conditions are known to affect haemostatic variables. We also excluded hypertensive subjects with acute illness and recent (o3 months) myocardial infarction, unstable angina, or stroke. The clinical characteristics of each subject are shown in Table 1 . Essential hypertension was defined as systolic BP X140 mmHg and/or diastolic BP X90 mmHg in-clinic and daytime ambulatory. In this study, WCHT was defined as a difference between CBP and ambulatory blood pressure (ABP) of at least 20 mmHg for systolic BP and/or 10 mmHg for diastolic BP. All patients gave their informed consent to participate in the study.
CBP measurements were performed in our outpatients unit by a standart mercury sphygmomanometer after 10 min resting. BP values were determined by the mean value of three consecutive measurements with 2-min intervals. Then all subjects were fitted with an ABP monitor for 24 h.
A portable noninvasive recorder (SpaceLabs Medical Devices, Inc., Redmond, WA, USA) was used in all studies and was programmed to record blood pressure every 30 min for 24 h.
This information was used to calculate the average ABP for each patient over the 24 h period.
The fibrinogen in plasma is assayed by the Clauss method by using the kit 'multifibren U' in BCT coagulation analyser, Dade Behring Marburg GmbH, Marburg/Germany. D-Dimer is assayed by the D-Dimer PLUS kit that is a latex-enhanced turbidimetric test for the quantitative determination of cross-linked fibrin degradation products in plasma (D-Dimer) for use with a Dade Behring Coagulation Analyzer ((BCT) Dade Behring Marburg GmbH, Marburg/Germany).
Statistical analysis was performed by KruskalWallis, Mann-Whitney U, and Spearman's correlation tests. Po0.05 was accepted as statistically significant. The values were recorded as median, minimum, and maximum.
The median levels of plasma fibrinogen were 428 (372-538) mg/dl in patients with essential hypertension, and 330 (247-444) mg/dl in patients with WCHT (Po0.001). In the control group, median levels of plasma fibrinogen (205 (188-247) mg/dl)) were lower than patients with WCHT (Po0.001) ( Table 1) .
The median levels of plasma D-dimer were 685 (549-778) mg/l in patients with sustained hypertension, and 575 (494-675) mg/l in patients with WCHT (Po0.001). In the control group, the median level of plasma D-dimer (476 (450-545) mg/l)) was lower than patients with WCHT (Po0.001) ( Table 1 ). The levels of plasma fibrinogen and D-dimer were related to diastolic BP (clinical and ambulatory) in patients with essential and WCHT (Po0.05).
Several prospective investigations have demonstrated a direct relationship between plasma fibrinogen concentrations and the risk of atherosclerotic cardiovascular disease. 5 In our study, levels of plasma fibrinogen in patients with EHT and WCHT were higher than in the healthy group. Lip et al 4 demonstrated that fibrinogen levels are related to the left ventricular mass in hypertensive patients. Similarly, Sechi et al 7 have reported a strong and independent association between fibrinogen and the presence and severity of hypertension-related damage in different organs. In our study, we found that the fibrinogen concentrations were related to diastolic BP (clinical and ambulatory) in patients with essential and WCHT.
Fibrin D-dimer is a fragment of crosslinked fibrin, and a good biochemical marker of thrombosis. 8 In our study, we found elevated plasma D-dimer levels in essential hypertension and WCHT groups. Lip et al. 4 have reported elevated D-dimer levels in hypertensive patients. Sechi et al. 7 reported that Ddimer concentrations were significantly related to the severity of targed organe damage in hypertensive patients. In one previous study, in patients with left ventricular hypertrophy, left ventricular enlargement, and left atrial enlargement, higher levels of D-dimer were detected. 9 Vaziri et al 10 found that D-dimer concentrations were related to diastolic BP. Similarly, in our study, we found that D-dimer concentrations were related to diastolic BP (clinical and ambulatory) in patients with essential and WCHT.
WCHT has been largely studied in the last decade, but there has been no consensus about its clinical importance and therapy requirement. 11 In the literature, levels of plasma fibrinogen and D-dimer in subjects with white WCHT have not been studied. In our study, plasma levels of fibrinogen and Ddimer were higher than the control group. Our data suggest that WCHT subjects, without other cardiovascular risk factors, revealed abnormalities of haemorheologic and thrombogenesis, although it was lower than patients with essential hypertension, and WCHT in adults may not be an innocent phenomenon; probably WCHT may progress to essential hypertension. E Çoban 1 , M Ö zdoǧan 2 and F Akçit 
